Back

Utility of ST2 soluble biomarker in patients with atrial fibrillation and pulmonary veins isolation

16 April 2023 (14:50 - 15:40)
Organised by:
Congress Presentation Part of: ePoster session 13 Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Carlos Minguito Carazo

Clinic Hospital Santiago de Compostela, A Coruna (Spain)

7 More presentations in this session

Presentation thumbnail
Impact of catheter ablation for persistent atrial fibrillation with heart failure, compared to preserved and reduced ejection fraction
Doctor Y. Inamura (Saitama, JP)
Abstract Slides
Presentation thumbnail
Consideration of technique for prevention of phrenic nerve injury due to right pulmonary vein ablation of atrial fibrillation
Doctor M. Tanaka (Kobe, JP)
Abstract Slides
Presentation thumbnail
One-year follow-up after pulmonary vein isolation using pulsed field ablation for paroxysmal atrial fibrillation
Associate Professor K. Neven (Essen, DE)
Abstract Slides
Presentation thumbnail
3D intracardiac echocardiography for left atrial appendage sizing and percutaneous occlusion guidance
Doctor D. Della Rocca (Brussels, BE)
Abstract Slides
Presentation thumbnail
Brady- and tachyarrhythmias in paroxysmal atrial fibrillation: results from long-term continuous electrocardiographic monitoring in RACE V
Doctor M. Frausing (Aarhus, DK)
Abstract Slides

Access the full session

Session thumbnail
ePoster session 13

The Event

Event poster

EHRA 2023

16 April 2023 14:50 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources